Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 70 of 70 entries
Sorted by: Best Match Show Resources per page
Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review.

Cancers

Hagens ERC, van Berge Henegouwen MI, Gisbertz SS.
PMID: 32560226
Cancers (Basel). 2020 Jun 16;12(6). doi: 10.3390/cancers12061592.

Metastatic lymphatic mapping in esophageal cancer is important to determine the optimal extent of the radiation field in case of neoadjuvant chemoradiotherapy and lymphadenectomy when esophagectomy is indicated. The objective of this review is to identify the distribution pattern...

Cite
Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers (Basel). 2020;12(6)doi: 10.3390/cancers12061592.
Hagens, E. R. C., van Berge Henegouwen, M. I., & Gisbertz, S. S. (2020). Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers, 12(6), . https://doi.org/10.3390/cancers12061592
Hagens, Eliza R C, et al. "Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review." Cancers vol. 12,6 (2020). doi: https://doi.org/10.3390/cancers12061592
Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers (Basel). 2020 Jun 16;12(6). doi: 10.3390/cancers12061592. PMID: 32560226; PMCID: PMC7352338.
Copy Download .nbib Format: NLM
Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery.

Journal of thoracic disease

Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI.
PMID: 29707301
J Thorac Dis. 2018 Mar;10(3):1511-1521. doi: 10.21037/jtd.2018.02.81.

BACKGROUND: The aim of the present study is to identify the incidence and prognostic significance of lymph node metastases near the celiac trunk in patients who underwent neoadjuvant chemo(radio)therapy followed by esophagectomy.METHODS: Between March 1994 and September 2013 a...

Cite
Lagarde SM, Anderegg MCJ, Gisbertz SS, et al. Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery. J Thorac Dis. 2018;10(3):1511-1521doi: 10.21037/jtd.2018.02.81.
Lagarde, S. M., Anderegg, M. C. J., Gisbertz, S. S., Meijer, S. L., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., van Laarhoven, H. W. M., & van Berge Henegouwen, M. I. (2018). Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery. Journal of thoracic disease, 10(3), 1511-1521. https://doi.org/10.21037/jtd.2018.02.81
Lagarde, Sjoerd M, et al. "Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery." Journal of thoracic disease vol. 10,3 (2018): 1511-1521. doi: https://doi.org/10.21037/jtd.2018.02.81
Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery. J Thorac Dis. 2018 Mar;10(3):1511-1521. doi: 10.21037/jtd.2018.02.81. PMID: 29707301; PMCID: PMC5906332.
Copy Download .nbib Format: NLM
Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information.

Journal of thoracic disease

Saadeh LM, Slaman AE, Pinto E, Gisbertz SS, Cavallin F, Jezerskyte E, Alfieri R, Noteboom L, Bellissimo MC, Cagol M, Pirozzolo G, Castoro C, Scarpa M, van Berge Henegouwen MI.
PMID: 30233889
J Thorac Dis. 2018 Aug;10(8):5123-5130. doi: 10.21037/jtd.2018.07.117.

No abstract available.

Cite
Saadeh LM, Slaman AE, Pinto E, et al. Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information. J Thorac Dis. 2018;10(8):5123-5130doi: 10.21037/jtd.2018.07.117.
Saadeh, L. M., Slaman, A. E., Pinto, E., Gisbertz, S. S., Cavallin, F., Jezerskyte, E., Alfieri, R., Noteboom, L., Bellissimo, M. C., Cagol, M., Pirozzolo, G., Castoro, C., Scarpa, M., & van Berge Henegouwen, M. I. (2018). Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information. Journal of thoracic disease, 10(8), 5123-5130. https://doi.org/10.21037/jtd.2018.07.117
Saadeh, Luca M, et al. "Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information." Journal of thoracic disease vol. 10,8 (2018): 5123-5130. doi: https://doi.org/10.21037/jtd.2018.07.117
Saadeh LM, Slaman AE, Pinto E, Gisbertz SS, Cavallin F, Jezerskyte E, Alfieri R, Noteboom L, Bellissimo MC, Cagol M, Pirozzolo G, Castoro C, Scarpa M, van Berge Henegouwen MI. Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information. J Thorac Dis. 2018 Aug;10(8):5123-5130. doi: 10.21037/jtd.2018.07.117. PMID: 30233889; PMCID: PMC6129931.
Copy Download .nbib Format: NLM
Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy.

Journal of thoracic disease

He H, Gruartmoner G, Ince Y, van Berge Henegouwen MI, Gisbertz SS, Geerts BF, Ince C, Hollmann MW, Liu D, Veelo DP.
PMID: 30069335
J Thorac Dis. 2018 Jun;10(6):3399-3408. doi: 10.21037/jtd.2018.05.169.

BACKGROUND: Keeping adequate tissue perfusion during high-risk abdominal surgery is of utmost importance to decrease postoperative complications. The objective was to investigate the alteration in mean systemic filling pressure (MSFP), venous return (VR) and sublingual microcirculation during pneumoperitoneum and...

Cite
He H, Gruartmoner G, Ince Y, et al. Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy. J Thorac Dis. 2018;10(6):3399-3408doi: 10.21037/jtd.2018.05.169.
He, H., Gruartmoner, G., Ince, Y., van Berge Henegouwen, M. I., Gisbertz, S. S., Geerts, B. F., Ince, C., Hollmann, M. W., Liu, D., & Veelo, D. P. (2018). Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy. Journal of thoracic disease, 10(6), 3399-3408. https://doi.org/10.21037/jtd.2018.05.169
He, Huaiwu, et al. "Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy." Journal of thoracic disease vol. 10,6 (2018): 3399-3408. doi: https://doi.org/10.21037/jtd.2018.05.169
He H, Gruartmoner G, Ince Y, van Berge Henegouwen MI, Gisbertz SS, Geerts BF, Ince C, Hollmann MW, Liu D, Veelo DP. Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy. J Thorac Dis. 2018 Jun;10(6):3399-3408. doi: 10.21037/jtd.2018.05.169. PMID: 30069335; PMCID: PMC6051808.
Copy Download .nbib Format: NLM
18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).

JAMA surgery

Gertsen EC, Brenkman HJF, van Hillegersberg R, van Sandick JW, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, Wijnhoven BPL, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Grieken NCT, Heisterkamp J, van Etten B, van den Berg JW, Pierie JP, Eker HH, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wevers KP, Hol L, Wessels FJ, Haj Mohammad N, van der Meulen MP, Frederix GWJ, Vegt E, Siersema PD, Ruurda JP.
PMID: 34705049
JAMA Surg. 2021 Dec 01;156(12):e215340. doi: 10.1001/jamasurg.2021.5340. Epub 2021 Dec 08.

IMPORTANCE: The optimal staging for gastric cancer remains a matter of debate.OBJECTIVE: To evaluate the value of 18F-fludeoxyglucose-positron emission tomography with computed tomography (FDG-PET/CT) and staging laparoscopy (SL) in addition to initial staging by means of gastroscopy and CT...

Cite
Gertsen EC, Brenkman HJF, van Hillegersberg R, et al. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). JAMA Surg. 2021;156(12):e215340doi: 10.1001/jamasurg.2021.5340.
Gertsen, E. C., Brenkman, H. J. F., van Hillegersberg, R., van Sandick, J. W., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., van Lanschot, J. J. B., Lagarde, S. M., Wijnhoven, B. P. L., de Steur, W. O., Hartgrink, H. H., Stoot, J. H. M. B., Hulsewe, K. W. E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Grieken, N. C. T., Heisterkamp, J., van Etten, B., van den Berg, J. W., Pierie, J. P., Eker, H. H., Thijssen, A. Y., Belt, E. J. T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W. M., Wevers, K. P., Hol, L., Wessels, F. J., Haj Mohammad, N., van der Meulen, M. P., Frederix, G. W. J., Vegt, E., Siersema, P. D., Ruurda, J. P. (2021). 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). JAMA surgery, 156(12), e215340. https://doi.org/10.1001/jamasurg.2021.5340
Gertsen, Emma C, et al. "18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC)." JAMA surgery vol. 156,12 (2021): e215340. doi: https://doi.org/10.1001/jamasurg.2021.5340
Gertsen EC, Brenkman HJF, van Hillegersberg R, van Sandick JW, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, Wijnhoven BPL, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Grieken NCT, Heisterkamp J, van Etten B, van den Berg JW, Pierie JP, Eker HH, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wevers KP, Hol L, Wessels FJ, Haj Mohammad N, van der Meulen MP, Frederix GWJ, Vegt E, Siersema PD, Ruurda JP. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). JAMA Surg. 2021 Dec 01;156(12):e215340. doi: 10.1001/jamasurg.2021.5340. Epub 2021 Dec 08. PMID: 34705049; PMCID: PMC8552113.
Copy Download .nbib Format: NLM
Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses.

Annals of surgical oncology

van Kooten RT, Voeten DM, Steyerberg EW, Hartgrink HH, van Berge Henegouwen MI, van Hillegersberg R, Tollenaar RAEM, Wouters MWJM.
PMID: 34482453
Ann Surg Oncol. 2022 Feb;29(2):1358-1373. doi: 10.1245/s10434-021-10734-3. Epub 2021 Sep 05.

OBJECTIVE: The aim of this study is to identify preoperative patient-related prognostic factors for anastomotic leakage, mortality, and major complications in patients undergoing oncological esophagectomy.BACKGROUND: Esophagectomy is a high-risk procedure with an incidence of major complications around 25% and...

Cite
van Kooten RT, Voeten DM, Steyerberg EW, et al. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Ann Surg Oncol. 2021;29(2):1358-1373doi: 10.1245/s10434-021-10734-3.
van Kooten, R. T., Voeten, D. M., Steyerberg, E. W., Hartgrink, H. H., van Berge Henegouwen, M. I., van Hillegersberg, R., Tollenaar, R. A. E. M., & Wouters, M. W. J. M. (2022). Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Annals of surgical oncology, 29(2), 1358-1373. https://doi.org/10.1245/s10434-021-10734-3
van Kooten, Robert T, et al. "Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses." Annals of surgical oncology vol. 29,2 (2022): 1358-1373. doi: https://doi.org/10.1245/s10434-021-10734-3
van Kooten RT, Voeten DM, Steyerberg EW, Hartgrink HH, van Berge Henegouwen MI, van Hillegersberg R, Tollenaar RAEM, Wouters MWJM. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Ann Surg Oncol. 2022 Feb;29(2):1358-1373. doi: 10.1245/s10434-021-10734-3. Epub 2021 Sep 05. PMID: 34482453.
Copy Download .nbib Format: NLM
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).

Clinical cancer research : an official journal of the American Association for Cancer Research

van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM.
PMID: 33504550
Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27.

PURPOSE: The CROSS trial established neoadjuvant chemoradiotherapy (nCRT) for patients with resectable esophageal adenocarcinoma (rEAC). In the PERFECT trial, we investigated the feasibility and efficacy of nCRT combined with programmed-death ligand-1 (PD-L1) inhibition for rEAC.PATIENTS AND METHODS: Patients with...

Cite
van den Ende T, de Clercq NC, van Berge Henegouwen MI, et al. Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT). Clin Cancer Res. 2021;27(12):3351-3359doi: 10.1158/1078-0432.CCR-20-4443.
van den Ende, T., de Clercq, N. C., van Berge Henegouwen, M. I., Gisbertz, S. S., Geijsen, E. D., Verhoeven, R. H. A., Meijer, S. L., Schokker, S., Dings, M. P. G., Bergman, J. J. G. H. M., Haj Mohammad, N., Ruurda, J. P., van Hillegersberg, R., Mook, S., Nieuwdorp, M., de Gruijl, T. D., Soeratram, T. T. D., Ylstra, B., van Grieken, N. C. T., Bijlsma, M. F., Hulshof, M. C. C. M., & van Laarhoven, H. W. M. (2021). Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT). Clinical cancer research : an official journal of the American Association for Cancer Research, 27(12), 3351-3359. https://doi.org/10.1158/1078-0432.CCR-20-4443
van den Ende, Tom, et al. "Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,12 (2021): 3351-3359. doi: https://doi.org/10.1158/1078-0432.CCR-20-4443
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT). Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. PMID: 33504550.
Copy Download .nbib Format: NLM
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX.

Cancers

Stroes CI, Schokker S, Molenaar RJ, Mathôt RAA, Bijlsma MF, van der Woude SO, Belo Pereira JP, Hooijer GKJ, Verhoeven RHA, Cats A, Grootscholten C, van Sandick JW, Creemers GJ, Nieuwenhuijzen GAP, Haj Mohammad N, Ruurda JP, Meijer SL, Hulshof MCCM, van Berge Henegouwen MI, van Laarhoven HWM.
PMID: 33671266
Cancers (Basel). 2021 Feb 17;13(4). doi: 10.3390/cancers13040839.

We assessed the feasibility of adjuvant S-1 and oxaliplatin following neoadjuvant chemoradiotherapy (nCRT) and esophagectomy. Patients treated with nCRT (paclitaxel, carboplatin) and esophagectomy received six 21-day cycles with oxaliplatin (130 mg/m

Cite
Stroes CI, Schokker S, Molenaar RJ, et al. A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers (Basel). 2021;13(4)doi: 10.3390/cancers13040839.
Stroes, C. I., Schokker, S., Molenaar, R. J., Mathôt, R. A. A., Bijlsma, M. F., van der Woude, S. O., Belo Pereira, J. P., Hooijer, G. K. J., Verhoeven, R. H. A., Cats, A., Grootscholten, C., van Sandick, J. W., Creemers, G. J., Nieuwenhuijzen, G. A. P., Haj Mohammad, N., Ruurda, J. P., Meijer, S. L., Hulshof, M. C. C. M., van Berge Henegouwen, M. I., & van Laarhoven, H. W. M. (2021). A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers, 13(4), . https://doi.org/10.3390/cancers13040839
Stroes, Charlotte I, et al. "A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX." Cancers vol. 13,4 (2021). doi: https://doi.org/10.3390/cancers13040839
Stroes CI, Schokker S, Molenaar RJ, Mathôt RAA, Bijlsma MF, van der Woude SO, Belo Pereira JP, Hooijer GKJ, Verhoeven RHA, Cats A, Grootscholten C, van Sandick JW, Creemers GJ, Nieuwenhuijzen GAP, Haj Mohammad N, Ruurda JP, Meijer SL, Hulshof MCCM, van Berge Henegouwen MI, van Laarhoven HWM. A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers (Basel). 2021 Feb 17;13(4). doi: 10.3390/cancers13040839. PMID: 33671266; PMCID: PMC7922275.
Copy Download .nbib Format: NLM
Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial.

JAMA surgery

van Workum F, Verstegen MHP, Klarenbeek BR, Bouwense SAW, van Berge Henegouwen MI, Daams F, Gisbertz SS, Hannink G, Haveman JW, Heisterkamp J, Jansen W, Kouwenhoven EA, van Lanschot JJB, Nieuwenhuijzen GAP, van der Peet DL, Polat F, Ubels S, Wijnhoven BPL, Rovers MM, Rosman C.
PMID: 33978698
JAMA Surg. 2021 Jul 01;156(7):601-610. doi: 10.1001/jamasurg.2021.1555.

BACKGROUND: Transthoracic minimally invasive esophagectomy (MIE) is increasingly performed as part of curative multimodality treatment. There appears to be no robust evidence on the preferred location of the anastomosis after transthoracic MIE.OBJECTIVE: To compare an intrathoracic with a cervical...

Cite
van Workum F, Verstegen MHP, Klarenbeek BR, et al. Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial. JAMA Surg. 2021;156(7):601-610doi: 10.1001/jamasurg.2021.1555.
van Workum, F., Verstegen, M. H. P., Klarenbeek, B. R., Bouwense, S. A. W., van Berge Henegouwen, M. I., Daams, F., Gisbertz, S. S., Hannink, G., Haveman, J. W., Heisterkamp, J., Jansen, W., Kouwenhoven, E. A., van Lanschot, J. J. B., Nieuwenhuijzen, G. A. P., van der Peet, D. L., Polat, F., Ubels, S., Wijnhoven, B. P. L., Rovers, M. M., Rosman, C. (2021). Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial. JAMA surgery, 156(7), 601-610. https://doi.org/10.1001/jamasurg.2021.1555
van Workum, Frans, et al. "Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial." JAMA surgery vol. 156,7 (2021): 601-610. doi: https://doi.org/10.1001/jamasurg.2021.1555
van Workum F, Verstegen MHP, Klarenbeek BR, Bouwense SAW, van Berge Henegouwen MI, Daams F, Gisbertz SS, Hannink G, Haveman JW, Heisterkamp J, Jansen W, Kouwenhoven EA, van Lanschot JJB, Nieuwenhuijzen GAP, van der Peet DL, Polat F, Ubels S, Wijnhoven BPL, Rovers MM, Rosman C. Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial. JAMA Surg. 2021 Jul 01;156(7):601-610. doi: 10.1001/jamasurg.2021.1555. PMID: 33978698; PMCID: PMC8117060.
Copy Download .nbib Format: NLM
Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study.

Annals of surgery

Claassen L, Hannink G, Luyer MDP, Ainsworth AP, van Berge Henegouwen MI, Cheong E, Daams F, van Det MJ, van Duijvendijk P, Gisbertz SS, Gutschow CA, Heisterkamp J, Kauppi JT, Klarenbeek BR, Kouwenhoven EA, Langenhoff BS, Larsen MH, Martijnse IS, van Nieuwenhoven EJ, van der Peet DL, Pierie JEN, Pierik REGJM, Polat F, Räsänen JV, Rouvelas I, Sosef MN, Wassenaar EB, van den Wildenberg FJH, van der Zaag ES, Nilsson M, Nieuwenhuijzen GAP, van Workum F, Rosman C.
PMID: 33605581
Ann Surg. 2021 Feb 10; doi: 10.1097/SLA.0000000000004801. Epub 2021 Feb 10.

OBJECTIVE: To describe the pooled learning curves of Ivor Lewis TMIE in hospitals stratified by predefined hospital and surgeon related factors.SUMMARY BACKGROUND DATA: Ivor Lewis totally minimally invasive esophagectomy (TMIE) is known to have a long learning curve which...

Cite
Claassen L, Hannink G, Luyer MDP, et al. Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Ann Surg. 2021;doi: 10.1097/SLA.0000000000004801.
Claassen, L., Hannink, G., Luyer, M. D. P., Ainsworth, A. P., van Berge Henegouwen, M. I., Cheong, E., Daams, F., van Det, M. J., van Duijvendijk, P., Gisbertz, S. S., Gutschow, C. A., Heisterkamp, J., Kauppi, J. T., Klarenbeek, B. R., Kouwenhoven, E. A., Langenhoff, B. S., Larsen, M. H., Martijnse, I. S., van Nieuwenhoven, E. J., van der Peet, D. L., Pierie, J. E. N., Pierik, R. E. G. J. M., Polat, F., Räsänen, J. V., Rouvelas, I., Sosef, M. N., Wassenaar, E. B., van den Wildenberg, F. J. H., van der Zaag, E. S., Nilsson, M., Nieuwenhuijzen, G. A. P., van Workum, F., Rosman, C. (2021). Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000004801
Claassen, Linda, et al. "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000004801
Claassen L, Hannink G, Luyer MDP, Ainsworth AP, van Berge Henegouwen MI, Cheong E, Daams F, van Det MJ, van Duijvendijk P, Gisbertz SS, Gutschow CA, Heisterkamp J, Kauppi JT, Klarenbeek BR, Kouwenhoven EA, Langenhoff BS, Larsen MH, Martijnse IS, van Nieuwenhoven EJ, van der Peet DL, Pierie JEN, Pierik REGJM, Polat F, Räsänen JV, Rouvelas I, Sosef MN, Wassenaar EB, van den Wildenberg FJH, van der Zaag ES, Nilsson M, Nieuwenhuijzen GAP, van Workum F, Rosman C. Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Ann Surg. 2021 Feb 10; doi: 10.1097/SLA.0000000000004801. Epub 2021 Feb 10. PMID: 33605581.
Copy Download .nbib Format: NLM
Showing 169 to 70 of 70 entries